Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 933
Healthy volunteers: no

Brief summary:
The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)

Detailed description:

Arms:
arm 1: Aclidinium Bromide 400 μg / Formoterol Fumarate 12 μg BID for 24 Weeks arm 2: Salmeterol 50 μg / Fluticasone propionate 500 μg BID for 24 Weeks

Interventions: intervention 1: Aclidinium Bromide / Formoterol Fumarate intervention 2: Salmeterol / Fluticasone
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: